论著
ENGLISH ABSTRACT
结直肠癌组织癌胚抗原相关黏附因子19表达及其对不良预后的评估价值
随冬侠
姜庆龙
曲冰洁
高桂华
作者及单位信息
·
DOI: 10.3760/cma.j.issn.1673-4904.2020.01.017
Expression of carcinoembryonic antigen-related cell adhesion molecule 19 and its prognostic significance in colorectal cancer
Sui Dongxia
Jiang Qinglong
Qu Bingjie
Gao Guihua
Authors Info & Affiliations
Sui Dongxia
Department of Oncology, Beijing Huairou Hospital, Beijing 101400, China
Jiang Qinglong
Department of General, Cancer Hospital Chinese Academy of Medical Sciences, Beijing 100021, China
Qu Bingjie
Department of Pathology, Beijing Huairou Hospital, Beijing 101400, China
Gao Guihua
Department of Oncology, Beijing Huairou Hospital, Beijing 101400, China
·
DOI: 10.3760/cma.j.issn.1673-4904.2020.01.017
429
26
0
0
0
0
PDF下载
APP内阅读
摘要

目的探讨结直肠癌组织癌胚抗原相关黏附因子19(CEACAM19)的表达及其对结直肠癌预后评估的价值。

方法入选2015年7月至2018年7月北京怀柔医院结直肠癌患者98例,采用免疫组织化学法检测癌组织和癌旁组织(距肿瘤切缘>2 cm)CEACAM19蛋白表达水平,分析CEACAM19表达与临床病理参数的关系,单因素和多因素Cox回归分析影响患者预后的因素。Kaplan-Meier法绘制生存曲线。

结果癌组织CEACAM19高表达率明显高于癌旁组织[69.4%(68/98)比16.3%(16/98)],差异有统计学意义( χ 2 = 45.060, P<0.01)。癌组织CEACAM19表达与TNM分期有关( P<0.05),与年龄、性别、肿瘤直径、分化程度、肿瘤位置、淋巴结分期、侵袭深度无关( P>0.05)。单因素Cox回归分析结果显示,淋巴结分期、TNM分期和CEACAM19表达是影响结直肠癌患者总体生存的危险因素( P<0.05或<0.01),TNM分期和CEACAM19表达是影响结直肠癌患者无病生存的危险因素( P<0.01)。多因素Cox回归分析结果显示,TNM分期增加和CEACAM19高表达是影响结直肠癌患者总体生存( HR = 2.628和0.199,95% CI 1.147~6.021和0.045~0.868, P = 0.022和0.032)和无病生存( HR = 2.009和0.303,95% CI 0.965~4.185和0.101~0.911, P = 0.048和0.034)不良预后的独立危险因素。生存曲线分析结果显示,CEACAM19低表达结直肠癌患者中位总体生存时间和无病生存时间明显长于CEACAM19高表达结直肠癌患者(47.9个月比27.8月和43.2个月比26.3个月, P<0.01)。TNM分期Ⅰ~Ⅱ期结直肠患者中位总体生存时间和无病生存时间明显长于TNM分期Ⅲ期结直肠癌患者(43.9个月比24.2个月和39.3个月比23.7个月, P<0.01)。

结论结直肠癌患者癌组织CEACAM19呈高表达,CEACAM19可以作为评估结直肠癌患者预后的指标。

结直肠肿瘤;预后;无病生存;癌胚抗原相关黏附因子19
ABSTRACT

ObjectiveTo investigate the expression of carcinoembryonic antigen-related cell adhesion molecule 19 (CEACAM19) in colorectal cancer tissues, and evaluate the clinical pathological characters and prognostic significance.

MethodsNinety-eight patients with colorectal cancer in Beijing Huairou Hospital from July 2015 to July 2018 were selected. The expression level of CEACAM19 protein in primary colorectal cancer and corresponding non-tumor tissues (>2 cm) was detected by immunohistochemistry. The correlation between clinical pathological characters and CEACAM19 expression level was analyzed. The prognostic influencing factors were analyze by univariate and multivariate Cox regression methods. Survival curve was drawn by Kaplan-Meier method.

ResultsThe high expression rate of CEACAM19 in colorectal cancer tissues was significantly higher than that in adjacent non-tumor tissues: 69.4% (68/98) vs. 16.3% (16/98), and there was statistical difference ( χ 2 = 45.060; P<0.01). Expression of CEACAM19 in colorectal cancer tissues was significantly associated with TNM stage ( P<0.05), and was not associated with age, gender, tumor diameter, histological differentiation, tumor location, lymph node stage and invasion depth ( P>0.05). Univariate Cox regression analysis result showed that lymph node stage, TNM stage and CEACAM19 expression were influencing factors of overall survival in patients with colorectal cancer ( P<0.05 or <0.01), and the TNM stage and CEACAM19 expression were influencing factors of disease-free survival in patients with colorectal cancer ( P<0.01). Multivariate Cox regression analysis result showed that TNM stage increased and CEACAM19 high expression were independent risk factors of overall survival ( HR = 2.628 and 0.199, 95% CI 1.147 to 6.021 and 0.045 to 0.868, P = 0.022 and 0.032) and disease-free survival ( HR = 2.009 and 0.303, 95% CI 0.965 to 4.185 and 0.101 to 0.911, P = 0.048 and 0.034) in patients with colorectal cancer. Survival curve analysis result showed that the median overall survival and disease-free survival in CEACAM19 low expression patients were significantly longer than CEACAM19 high expression patients (47.9 months vs. 27.8 months and 43.2 months vs. 26.3 months, P<0.01); the median overall survival and disease-free survival in TNM Ⅰ to Ⅱ stage were significantly longer than TNM Ⅲ stage patients (43.9 months vs. 24.2 months and 39.3 months vs. 23.7 months, P<0.01).

ConclusionsThe CEACAM19 in colorectal cancer tissues is high expression, and the CEACAM19 expression level can be used as biomarker for prediction the prognosis of colorectal cancer.

Colorectal neoplasms;Prognosis;Disease-free survival;Carcinoembryonic antigen-related cell adhesion molecule 19
Sui Dongxia, Email: mocdef.3ab61321aixgnodius, Tel: 0086-10-69622761-8603
引用本文

随冬侠,姜庆龙,曲冰洁,等. 结直肠癌组织癌胚抗原相关黏附因子19表达及其对不良预后的评估价值[J]. 中国医师进修杂志,2020,43(1):70-75.

DOI:10.3760/cma.j.issn.1673-4904.2020.01.017

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
结直肠癌(colorectal cancer,CRC)是常见的肠道恶性肿瘤,其发病率和病死率分别居全球第3位和第4位 [ 1 , 2 ]。尽管近20年癌症治疗技术得到了快速发展,但是其5年存活率依然低于50% [ 3 ]。究其原因,可能与晚期复发和转移有关。因此,早期筛查出具有高危复发转移的患者对降低结直肠癌病死率具有重要意义。癌胚抗原(CEA)、癌抗原19-9(CA19-9)等是结直肠癌常用的诊断和评估预后的肿瘤标志物,但是其特异度和敏感度均较低 [ 4 , 5 ],使其临床应用受限。癌胚抗原相关黏附因子19(carcinoembryonic antigen-related cell adhesion molecule 19,CEACAM19)是最新发现的癌胚抗原家族成员,属于免疫球蛋白超家族黏附分子。CEACAM19广泛表达于上皮细胞,在细胞增殖、淋巴细胞活化以及血管形成等方面发挥着重要的生物学功能 [ 6 ]。研究结果显示,CEACAM19在乳腺癌、胃癌等上皮性恶性肿瘤中特异性高表达,并介导肿瘤细胞增殖、迁移和侵袭等生物学过程;CEACAM19表达水平与肿瘤患者预后密切相关 [ 7 , 8 ]。但是目前关于CEACAM19与结直肠癌关系的研究较少。鉴于此,本研究通过免疫组织化学染色方法检测结直肠癌患者CEACAM19表达情况,并观察其与预后的关系,旨在探讨CEACAM19作为结直肠癌预后评估指标的可能性。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Deng X , Ao S , Hou J ,et al. Prognostic significance of periostin in colorectal cancer[J]. Chin J Cancer Res, 2019,31(3):547-556. DOI: 10.21147/j.issn.1000-9604.2019.03.16 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Siegel RL , Miller KD , Jemal A . Cancer statistics, 2017[J]. CA Cancer J Clin, 2017,67(1):7-30. DOI: 10.3322/caac.21387 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Yu H , Hemminki A , Sundquist K ,et al. Familial associations of colorectal cancer with other cancers[J]. Sci Rep, 2017,7(1):5243. DOI: 10.1038/s41598-017-05732-z .
返回引文位置Google Scholar
百度学术
万方数据
[4]
刘万超权文强吴军录,. 人血清外泌体癌胚抗原检测在结直肠癌诊断中的临床应用[J]. 中华检验医学杂志, 2018,41(7):503-508. DOI: 10.3760/cma.j.issn.1009-9158.2018.07.005 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Zhong W , Yu Z , Zhan J ,et al. Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer[J]. Pathol Oncol Res, 2015,21(1):83-95. DOI: 10.1007/s12253-014-9791-9 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
于洪涛唐大海. 癌胚抗原相关细胞黏附因子19与乳腺癌相关基因关系[J]. 中国公共卫生, 2016,32(1):105-107. DOI: 10.11847/zgggws2016-32-01-31 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Zhao H , Xu J , Wang Y ,et al. Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K/Akt and NF-κB[J]. Surg Oncol, 2018,27(3):495-502. DOI: 10.1016/j.suronc.2018.05.003 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Estiar MA , Esmaeili R , Zare AA ,et al. High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer[J]. Clin Exp Med, 2017,17(4):547-553. DOI: 10.1007/s10238-016-0442-1 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Compérat E , Varinot J , Eymerit C ,et al. Comparison of UICC and AJCC 8th edition TNM classifications in uropathology[J]. Ann Pathol, 2019,39(2):158-166. DOI: 10.1016/j.annpat.2018.12.005 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Michaelidou K , Tzovaras A , Missitzis I ,et al. The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression[J]. Int J Oncol, 2013,42(5):1770-1777. DOI: 10.3892/ijo.2013.1860 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Feige MH , Sokolova O , Pickenhahn A ,et al. HopQ impacts the integrin α5β1-independent NF-κB activation by Helicobacter pylori in CEACAM expressing cells[J]. Int J Med Microbiol, 2018,308(5):527-533. DOI: 10.1016/j.ijmm.2018.05.003 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Aqil M , Elseth KM , Arjunakani A ,et al. A549 cells adapted to high nitric oxide show reduced surface CEACAM expression and altered adhesion and migration properties[J]. Tumour Biol, 2015,36(3):1871-1879. DOI: 10.1007/s13277-014-2789-9 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Zhao Q , Busch B , Jiménez-Soto LF ,et al. Integrin but not CEACAM receptors are dispensable for Helicobacter pylori CagA translocation[J]. PLoS Pathog, 2018,14(10):e1007359. DOI: 10.1371/journal.ppat.1007359 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
夏龙飞刘玉君张军民,. CEACAM-1在结直肠癌中的表达及与肿瘤血管生成、转移的相关性研究[J]. 中国医药导报, 2019,16(2):94-97;封4.
返回引文位置Google Scholar
百度学术
万方数据
[15]
Hasselbalch HC , Skov V , Larsen TS ,et al. High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis[J]. Leuk Res, 2011,35(10):1330-1334. DOI: 10.1016/j.leukres.2011.03.013 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
郭飞林杨张鹏程,. 结直肠癌组织中CEACAM-1、NET-1的表达变化及其意义[J]. 山东医药, 2018,58(23):48-50. DOI: 10.3969/j.issn.1002-266X.2018.23.014 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
弋惠茹罗兴育尹利,. 黏附分子CD 44在呼吸道合胞病毒感染致毛细支气管炎中的作用 [J]. 中国医师进修杂志, 2014,37(27):23-25. DOI: 10.3760/cma.j.issn.1673-4904.2014.27.009 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Huajun W , Ying F , Hongxing Z ,et al. Clinical value of combined detection of serum APE1-Aabs and CEACAM-1 in the diagnosis of colorectal cancer[J]. Eur Rev Med Pharmacol Sci, 2018,22(5):1286-1289. DOI: 10.26355/eurrev_201803_14469 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
朱晓敏郭春龙高羽,. 表皮生长因子受体酪氨酸激酶抑制剂联合含铂类化疗方案和全脑放疗治疗非小细胞肺癌脑转移的研究[J]. 中国医师进修杂志, 2019,42(2):109-114. DOI: 10.3760/cma.j.issn.1673-4904.2019.02.004 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Han ZM , Huang HM , Sun YW . Effect of CEACAM-1 knockdown in human colorectal cancer cells[J]. Oncol Lett, 2018,16(2):1622-1626. DOI: 10.3892/ol.2018.8835 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
随冬侠,Email: mocdef.3ab61321aixgnodius,电话:010-69622761-8603
B
所有作者均声明不存在利益冲突
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号